Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes
| Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes |
| Autore | Ylostalo Joni H |
| Descrizione fisica | 1 online resource (204 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
3-methyladenine
3D culture adipose tissue-derived stem cells (ASCs) adipose-derived stem cell AKB-6548 angiogenesis astrocytes autophagy axon growth CD206 cell therapy chemotaxis combination therapy engineered cardiac patches exosome fibroblast growth factor 2 hepatocyte growth factor hypoxia IFN-γ immunomodulation immunosuppression iMSC secretome inflammation iPSC-derived MSCs liver cirrhosis macrophages malignant pleural mesothelioma (MPM) mesenchymal stem cells mesenchymal stromal cells mesothelioma nanofiber-hydrogel composite neural neuroprotection neurospheres osteogenic differentiation oxygen conditions paracrine potential phagocytosis placenta-derived mesenchymal stem cells pluripotency polyunsaturated fatty acid potentiation of iMSC efficacy pre-conditioning preconditioning priming quiescence rapamycin secondary injury secretome secretory profile spheroids spinal cord injury umbilical cord Vadadustat Wharton's jelly mesenchymal stem cells WKYMVm |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Enhancing Mesenchymal Stem Cells |
| Record Nr. | UNINA-9910595079403321 |
Ylostalo Joni H
|
||
| Lo trovi qui: Univ. Federico II | ||
| ||
Research of Pathogenesis and Novel Therapeutics in Arthritis / Chih-Hsin Tang
| Research of Pathogenesis and Novel Therapeutics in Arthritis / Chih-Hsin Tang |
| Autore | Tang Chih-Hsin |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 electronic resource (366 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
receptor activator of nuclear factor ?B
infliximab tripterine triptolide osteoblast tumor necrosis factor-alpha synovial cell anti-arthritis biosimilars Epstein-Barr virus cytokines SOX9 parathyroid hormone nitric oxide rat etanercept angiogenesis glycosylation mitogen activated protein kinase Th9 lymphocytes rheumatoid arthritis IL-6 clodronate bone erosion mesenchymal stem cells collagen-induced arthritis biological gene expression inflammatory arthritis osteoarthritis fraxinellone nuclear factor kappa B messenger RNA inflammation miRNA disease-modifying adipokines WNT glycoprotein 42 miR-199a-5p proliferation next-generation sequencing collagen osteoarthritis (OA) experimental arthritis bone morphogenetic protein TNF-? computational modeling basic research osteoclast therapeutics certolizumab pegol chondrocytes progenitor cells adjuvant arthritis adalimumab triterpenoid sclareol TNF? fibroblast growth factor 2 antibodies osteoblasts molecular pathology Th17 immunology obesity visfatin articular cartilage autoimmune biomarkers celastrol MAPK disease pathways IL1? arthritis bioinformatics anticitrullinated peptide antibodies drug delivery system antagonists shared epitope pathology SMA- and MAD-related protein small-molecule inhibitor transforming growth factor ? mice golimumab spinal fusion antirheumatic drug early osteoarthritis stem cell rheumatoid factor therapeutic antibody bisphosphonate osteoclastogenesis interleukin spondyloarthropathies clinical translation therapy Traditional Chinese medicine chemokines structure cell signaling microRNA |
| ISBN |
9783038970668
3038970662 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910346843303321 |
Tang Chih-Hsin
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||